Improved survival in stage III non-small-cell lung cancer: Seven-years follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. - Dillman,RO.; Herndon,J.; Seagren,SL. (J Natl Cancer Inst, 1996)